Crocin Mitigates Age Related Sarcopenia in Rats By Increased Mitochondrial Activity and Up-Regulation of Nrf2/HO-1 Pathway | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 12, Volume 99, Issue 1, April 2025, Page 1431-1437 PDF (758.89 K) | ||||
| DOI: 10.21608/ejhm.2025.421222 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Background: Sarcopenia has always been associated with aging and the elderly. It is thought that crocin has anti-inflammatory and antioxidant qualities. Objective: We looked at Crocin impact on age related sarcopeniaand its potential underlying molecular processes. Material and Methods: Thirty adult male rats were split into three groups: aged, control, and aged+crocin. In addition to muscle TNF-α, muscle IL-6, serum MIF, serum IGF-1, serum CK and muscle MDA assessment, rats were also assessed regarding EMG recordings, muscle citrate synthase, muscle GSH, and muscle Nrf-2, HO-1, and myogenin gene expression. The muscle was also evaluated histopathologically. Results: While the aged group's muscle TNF-α, muscle IL-6, serum MIF, serum CK, and muscle MDA were dramatically higher than the control, the aged group's measured mean frequency, mean power, muscle citrate synthase, serum IGF-1, muscle GSH, muscle Nrf-2, HO-1, and myogenin gene expression were significantly lower. Crocin significantly reduced age-related alterations. Conclusion: Through anti-oxidant, anti-inflammatory, and enhanced mitochondrial activity methods, as well as through up-regulating the expression of the Nrf-2, HO-1, and myogenin genes, crocin improved age-related sarcopenia. | ||||
| Keywords | ||||
| Crocin; Nrf-2; HO-1; Ageing; Sarcopenia; CK; IGF-1; Myogenin | ||||
|
Statistics Article View: 255 PDF Download: 143 |
||||
